English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Worldwide, liver cancer is the sixth most common tumor and the fourth leading cause of cancer-related deaths (1). China is a high-risk area for primary liver cancer (PLC), in which more than half of the world’s new cases of liver cancer occur each year (2). Hepatocellular carcinoma (HCC) is the most important type of PLC. At present, surgical resection is still the first choice for the treatment of early liver cancer, and the radical hepatectomy is an important means of obtaining longterm survival, however, the overall 5-year survival rate of Original Article

translational cancer research

Prognostic effect of systemic inflammation in patients undergoing surgery for hepatocellular carcinoma: comparison of composite ratios and cumulative scores